| Literature DB >> 26459834 |
Maksim Shestov1, Santiago Ontañón2, Aydin Tozeren3.
Abstract
BACKGROUND: Bacterial infections comprise a global health challenge as the incidences of antibiotic resistance increase. Pathogenic potential of bacteria has been shown to be context dependent, varying in response to environment and even within the strains of the same genus.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26459834 PMCID: PMC4603813 DOI: 10.1186/s12864-015-1957-7
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
List of bacterial genera highlighting the number of strains that have been associated with the pathogenic state, as well as the strains associated with the commensal state in the present study
| Total bacterial strain genomes | 2527 | ||||
|---|---|---|---|---|---|
| Total pathogenic bacterial strains | 949 | ||||
| KEGG based pathogenic strains | 767 | ||||
| Additional literature based pathogenic strains | 182 | ||||
| Genus | Total | Pathogenic | Genus | Total | Pathogenic |
| Streptococcusa | 120 | 77 | Rickettsiaa | 41 | 19 |
| Chlamydiaa | 98 | 81 | Burkholderiaa | 39 | 17 |
| Bacillusa | 81 | 22 | Listeriaa | 34 | 25 |
| Candidatusa | 71 | 4 | Campylobactera | 26 | 13 |
| Mycobacteriuma | 65 | 34 | Vibrio | 25 | 20 |
| Mycoplasmaa | 65 | 54 | Brucella | 20 | 18 |
| Escherichiaa | 64 | 39 | Acinetobacter | 19 | 12 |
| Helicobactera | 63 | 47 | Francisella | 19 | 13 |
| Pseudomonasa | 53 | 12 | Yersinia | 19 | 17 |
| Staphylococcusa | 51 | 42 | Borrelia | 18 | 14 |
| Corynebacteriuma | 50 | 34 | Neisseria | 18 | 18 |
| Clostridiuma | 49 | 22 | Treponema | 17 | 13 |
| Salmonellaa | 45 | 36 | Haemophilus | 16 | 13 |
The “a” identifies those genera for which we have also conducted within genus comparisons
Fig. 1Scatter diagram of relative abundance of 7194 orthologs found in 2527 decoded bacterial genomes. The horizontal axis represents the percentage of nonpathogenic strains presenting the ortholog (Anp) whereas the vertical axis represents the corresponding percentage in pathogenic strain subpopulation (Ap). The pathogen-abundant (PA > 4) and nonpathogen-abundant orthologs (PA < 0.25) were marked in red and green, respectively. Note that PA = Ap/Anp
Fig. 2Histogram showing the frequency of occurrence of orthologs with respect to the pathogen abundance score (PA). The two edges of the histogram (PA > 4, PA < 0.25) are marked in red and green, respectively
Fig. 3Pie charts indicating the distribution of orthologs of the present study with respect to ortholog abundance (3A) and the virulence factors presented by the VFDB web platform (3B) as a function of the pathogen abundance score PA
Fig. 4Pie chart for statistical enrichment of KEGG pathways by pathogen-abundant (PA > 4, red) and nonpathogen-abundant (PA < 0.25, blue) orthologs, respectively
Fig. 5Gene ontology molecular function distributions in pathogen-abundant orthologs (PA > 4, blue) and in VFDB (red), respectively
KEGG reference pathways, which are statistically enriched by orthologs abundant in antibiotics-resistant bacteria. Hypergeometric test assumes as background the set of pathogen-linked orthologs.
| Pathway | p value via hypergeometric test |
|---|---|
| D-Arginine and D-ornithine metabolism | 0.00572 |
| Amino sugar and nucleotide sugar metabolism | 0.0273 |
| Peptidoglycan biosynthesis | 0.00135 |
| Sphingolipid metabolism | 0.00524 |
| Aminoacyl-tRNA biosynthesis | 0.00076 |
| Phosphatidylinositol signaling system | 0.04909 |
| PI3K-Akt signaling pathway | 0.00384 |
| Amoebiasis | 0.03099 |
Gene circuits linked to pathogenic phenotype. Gene symbols in the table indicate orthologs in the circuit, which are abundant in pathogenic but rarely found in nonpathogenic strains
| Pathway | Circuit | Orthologs | Genera | |
|---|---|---|---|---|
| 1 | Two Component system | Mg2+ starvation, antimicrobial peptide | pagC, pagO, pagD, pagK, pgtE | S. enterica*, B. aphidicola, E. coli*, P. ananatis, Y. pseudotuberculosis |
| 2 | Two Component system | Hexose phosphate uptake | uhpC, uhpA, uhpT | C. trachomatis, E. coli*, S. enterica*, S. aureus, L. monocytogenes |
| 3 | Two Component system | Competence Stimulating Peptide | ABCC-BAC.COMA, comA, comB, comC, comD, comE | S. pneumoniae, L. casei, L. rhamnosus, S. equi, L. plantarum |
| 4 | Two Component system | Hypoxia,Oxygen, Nitrogen asssimilation | devS, nreA, nreB, narT | S. aureus*, M. tuberculosis, M. bovis, M. canettii, P. polymyxa |
| 5 | Two Component system | Phosphpglycerate transport | pgtC, pgtB, pgtA, pgtP | S. enterica*, C. jejuni, V. cholerae, K. pneumoniae, E. coli |
| 6 | Biosynthesis of siderophore group nonribosomal peptides | Yersiniabactin | irp1, HMWP1, irp5, ybtE, irp3, ybtU | E. coli* , Y. pestis, R. solanacearum, C. diphtheriae, K. pneumoniae |
| 7 | Biosynthesis of siderophore group nonribosomal peptides | Pyochelin | pchF, pchG, pchD, pchE | P. aeruginosa, B. pseudomallei, B. cenocepacia, A. dieselolei, A. lipoferum |
| 8 | Bacterial secretion system | Type III | yscF, yscO, yscP, yscX, yscC, yscW | C. trachomatis*, S. enterica, E. coli*, C. psittaci, P. aeruginosa |
| 9 | Bacterial secretion system | Type V | vacA, yadA, yadB_C | H. pylori*, Y. pestis, Y. pseudotuberculosis, Y. enterocolitica, H. cetorum |
| 10 | Peptidoglycan biosynthesis | Peptidoglycan branch | sgtA, sgtB, femA, pbpA, femB, | S. aureus, C. Arthromitus, E. sp., S. |
| 11 | Carotenoid biosynthesis | Terpenpid backbone to Staphyloxanthin | crtM, crtP, crtQ, K10212, crtO | S. aureus*, B. megaterium, C. sp., S. lugdunensis, B. infantis |
| 12 | Salmonella infection | Translocon | sipB, ipaB, bipB, sipC, ipaC, bipC, sipD, ipaD, bipD, sseB, sseC, sseD | S. enterica*, B. pseudomallei, E. coli*, S. baltica, B. mallei |
| 13 | Salmonella infection | Type III secretion system/SPI-2 encoded | sseJ, sifA, sseF, sseG, pipB2, sspH2, sseI, srfH, spvB | S. enterica*, S. baltica, E. tarda, Y. enterocolitica, C. violaceum |
| 14 | Pentose phosphate pathway | D-Glucosaminate metabolism | dgaA-dgaE, PTS-Dga-EIIA, PTS-Dga-EIID, PTS-Dga-EIIB, PTS-Dga-EIIC | S. enterica*, E. coli*, E. faecalis, C. difficile, L. casei |
| 15 | Bacterial invasion of epithelial cells | ECM-receptor interaction | pfbA, sfb1, fnbA, fnbB | S. aureus, S. pyogenes, S. pneumoniae, S. dysgalactiae, S. equi |
| 16 | Phosphotransferase system | Sorbose to Sorbose 1-phosphate | PTS-Sor-EIIC, sorA, PTS-Sor-EIID, sorM, PTS-Sor-EIIA, sorF, PTS-Sor-EIIB, sorB | E. coli*, K. pneumoniae, L. casei, L. rhamnosus, S. flexneri |
| 17 | Phosphotransferase system | D-Glucosaminate to D-Glucosaminate 6-P | PTS-Dga-EIIC, dgaA-dga-D, PTS-Dga-EIIA, PTS-Dga-EIID,, PTS-Dga-EIIB | S. enterica*, E. coli*, E. faecalis, C. difficile, L. casei |
| 18 | Amino nucleotide sugar metabolism | CMP-Pse metabolism | pseC, pseH, pseF, UAP1 | C. trachomatis, H. pylori*, C. jejuni, C. psittaci, P. acnes |
| 19 | Plant-pathogen interaction | Bacterial secretion system | hopAB, avrPtoB, avrPto1, avrRpm1, avrXccC, avrB | P. syringae, _., X. campestris, _. |
| 20 | Bacterial invasion of epithelial cells | Type III - Salmonella | sipA-sipD, ipaA-ipaD, bipD, bipC, bipB, sopD, sptP, sopE, ipgD, sopB | S. enterica, B. pseudomallei, E. coli, B. mallei, B. thailandensis |
| 21 | Bacterial invasion of epithelial cells | Type III - Shigella | sipC, ipaA-ipaC, bipC, sipB, bipB, ipgB1, espG, virA, ipgB2, ipgD, sopB | S. enterica, E. coli, B. pseudomallei, B. mallei, B. thailandensis |
| 22 | Vibrio cholerae infection | Type II secretion system | ctxA, ctxB, ace, rtxA | V. cholerae*, E. coli*, V. vulnificus, Y. enterocolitica, A. hydrophila |
| 23 | Vibrio cholerae infection | Type IV pilus | tcpA, tcpB, tcpC, tcpD, tcpE, tcpF | V. cholerae*, C. rodentium, E. cloacae, R. aquatilis, R. sp. |
| 24 | Vibrio cholerae pathogenic cycle | Quorum Sensing | luxQ, luxU, qrr, tcpB, K10917, aphA, tcpH, tcpP | V. cholerae*, V. vulnificus, V. fischeri, V. parahaemolyticus, V. sp. |
| 25 | Epithelial cell signaling in Helicobacter pylori infection | Type IV secretion system | cag1, cag2, cag1, cag2, cag3, virB11, lvhB11, cag7-cag25 | H. pylori*, R. prowazekii, L. pneumophila, R. rickettsii, S. meliloti |
| 26 | Epithelial cell signaling in Helicobacter pylori infection | Adhesins | hopC, alpA, hopB, alpB, hopZ, K15846, hpaA, sdbA, sabA | H. pylori*, L. pneumophila*, H. cetorum, H. acinonychis, H. bizzozeronii |
| 27 | Pathogenic Escherichia coli infection | Intimate adhesion/Type III secretion system | espG, virA, tir, espF, map, eae, nleA, nleH, espH, tccP, espG2 | E. coli*, S. flexneri, S. sonnei, C. rodentium, S. boydii |
| 28 | Shigellosis | Motility | icsA, virG, espG, virA, icsB, bopA | E. coli, B. pseudomallei, B. mallei, S. flexneri, S. sonnei |
| 29 | Shigellosis | Type III Secretion/Downsteam | ipgB1-2, ipaH9.8, ospE-G, espO, mkaD, sipA-D, ipaA-D, bipB-D, ipgD, sopB | S. enterica*, E. coli*, B. pseudomallei*, B. mallei*, E. tarda |
| 30 | Salmonella infection | Type III secretion system/SPI-1 encoded | sipB, ipaB, bipB, sopE, ipgD, sopB, sipA, ipaA, sptP, yopJ | S. enterica*, Y. pestis, B. pseudomallei, E. coli*, B. mallei* |
| 31 | Pertussis | Type IV secretion system | ptxD, ptxB, ptxE, ptxC, ptxA | S. enterica*, B. pertussis, Y. enterocolitica, B. bronchiseptica, B. parapertussis |
| 32 | Legionellosis | Adhesion/Cell entry | sdeA, laiA, rtxA1, rtxA, enhC, lpnE | L. pneumophila*, C. burnetii, L. longbeachae, |
| 33 | Legionellosis | Dot/Icm secretion system | ralF, lidA, sidC, legK1, lgt1_2_3, sidI,M, FlepB, vipA,D,E, sdbA, sdcA, drrA, lubX | L. pneumophila*, L. longbeachae, |
| 34 | Staphylococcus aureus infection | Colonization/MSCRMMs | clfB, isdA, sdrC_D_E, sasG | S. aureus*, C. pseudotuberculosis, S. epidermidis, S. pseudintermedius, E. casseliflavus |
| 35 | Staphylococcus aureus infection | Surface proteins | spa, sbi, clfA, sak, scn, scin, fib, efb, chp, chips, flr, flipr | S. aureus*, S. lugdunensis*, S. pseudintermedius, B. thuringiensis, S. carnosus |
The symbol * identifies those genera for which the circuit shown was also linked to pathogenicity via within-genus comparison
Nonpathogen-linked gene circuits in bacterial strains. The columns identify pathways, circuits, nonpathogen-linked orthologs within the circuit; and genera expressing the circuit
| Pathway | Circuit | Orthologs | Genera | |
|---|---|---|---|---|
| 1 | Steroid biosynthesis | Squalene to 24,25-Dihydro-lanosterol | SQLE, ERG1, E5.4.99.7, LSS, ERG7, DHCR24 | C. coralloides*, F. taffensis, M. capsulatus*, M. alcaliphilum, S. aurantiaca |
| 7 | Arginine and proline metabolism | N-Acetyl-glutamate - N-Acetyl-ornithine | argB, ARG56, argC, lysY, ARG56, E2.6.1.11, argD, argD, lysJ | E. coli*, S. enterica*, S. aureus*, L. monocytogenes, M. tuberculosis* |
| 3 | Biosynthesis of 12-, 14- and 16-membered macrolides | Propanoyl-CoA to Erythromycin A | E2.3.1.94, eryF, eryBV, eryCIII, eryCII, eryG, eryK | F. alni, S. erythraea, |
| 2 | Lysine biosynthesis | L-2-Amino adipate to Pyrrolysine | lysX, lysZ, lysY, lysJ, E2.4.1.173, pylB, pylC, pylD | T. thermophilus*, P. mucilaginosus, C. sp., D. hafniense, M. ruber |
| 5 | Glycine, serine and threonine metabolism | Choline - Glycine | codA, gbsB, BHMT, DMGDH, SARDH | B. amyloliquefaciens, B. subtilis, S. meliloti, R. sphaeroides, B. licheniformis |
| 6 | Arginine and proline metabolism | Creatine Pathway | GAMT, E2.7.3.2, E3.5.3.3, E3.5.1.59, hyuA, hyuB, E3.5.4.21 | H. pylori*, P. putida, C. sp., A. mediterranei, G. sp. |
| 11 | Type I polyketide structures | Rifamycin B | rifA, rif14, rifB, rif20, rifC_D, rifE, rifF, asm9, rif19 | A. mediterranei*, F. sp., A. mirum, M. aurantiaca, M. sp. |
| 4 | Biosynthesis of 12-, 14- and 16-membered macrolides | 2-Methylbutanoyl to Avermectin | aveA, aveE, aveF, aveD, aveBI | S. avermitilis. |
| 8 | Streptomycin biosynthesis | scyllo-inosamine | stsE, strB1, E2.4.2.27, strK, K12570, aphD, strA | S. griseus |
| 9 | Type I polyketide structures | Erythromycin A | eryK, E2.3.1.94, eryF, E2.3.1.94, eryCIII, eryCII, E2.3.1.94, eryBV | F. alni, S. erythraea. |
| 10 | Type I polyketide structures | Avermectin A1a | aveA, aveBI, aveE, aveF, aveD | S. avermitilis, |
| 12 | Type I polyketide structures | Myalamid S | mxaB, mxaE_D, mxaF | G. violaceus, H. ochraceum, H. aurantiacus, M. xanthus, N. punctiforme |
| 13 | Biosynthesis of type II polyketide backbone | 7,9,12-Octaketides | actI1, actI2, actI3, actIII, actVII | A. mediterranei*, F. sp., A. missouriensis, C. acidiphila*, C. epipsammum |
| 14 | Biosynthesis of type II polyketide products | 7,9,12-Octaketides - Actinorhodin | actVI1, RED1, actVI3, actVI2, actIV, actVI4, actVA6, actVIA, actVA5, actVB | A. mediterranei*, F. sp., M. abscessus, S. cattleya, A. ferrooxidans |
| 15 | Serotonergic synapse | Signal transduction | PLA2G4, CPLA2, ALOX5, PTGS2, COX2, PTGS2, COX2 | R. sphaeroides*, C. coralloides, G. obscurus, M. nodulans, M. sp. |
| 16 | Insulin signaling pathway | Glycogenesis/ antilipolysos | GYS, CALM, PHKA_B, PRKAR | S. sp., C. sp., A. sp., B. coagulans, C. sp. |
| 17 | Chemical carcinogenesis | Azo dyes/Liver cancer/Bladder cancer | PTGS2, COX2, CYP1A1 | R. sphaeroides*, G. obscurus, M. mediterranea, M. nodulans, M. sp. |
The symbol * indicates those genera for which the circuitry was linked to synergy via within genus comparison
Fig. 6Examples of gene circuitry containing pathogen-linked ortholog clusters in KEGG reference pathways. Orthologs with PA > 4 but not present in VFDB were shaded in pink whereas orthologs with PA > 4 and also in VFDB in orange. The numbers indicating specific circuitry correspond to their identification numbers in Table 3
Fig. 7Examples of gene circuitry in KEGG Reference pathways, which are linked to pathogenicity via within-genus comparison. The orthologs linked to pathogenicity in these circuits are shaded in pink. The numbers indicating specific circuitry correspond to their identification numbers in Additional file 5
Fig. 8Examples of gene circuitry containing nonpathogen-linked ortholog clusters in KEGG reference pathways. Orthologs with PA < 1/4 are shaded in pink. The numbers indicating specific circuitry correspond to their identification numbers in Table 4